• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2017 - 2019年乌干达全国预防母婴传播艾滋病毒项目及母婴传播相关因素的影响评估

An impact evaluation of the national prevention of mother to child HIV transmission program and MTCT associated factors in Uganda 2017-2019.

作者信息

Nabitaka Linda Kisaakye, Delaney Augustina, Namukanja Phoebe M, Nalugoda Fred, Makumbi Fredrick E, Dirlikov Emilio, Nelson Lisa, Kirungi Wilford, Sendagala Sam, Nakityo Rose B, Kasule Jingo, Ondo Doreen, Mudiope Peter, Ssewanyana Isaac, Opio Joel, Thu-Ha Dinh, Adler Michelle R, Asiimwe Hilda, Birabwa Estella, Ochora Esther Nyamugisa, Serwadda David, Lutalo Tom

机构信息

Uganda Ministry of Health, AIDS Control Programme, Kampala, Uganda.

Global Health Center, Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.

出版信息

Sci Rep. 2025 Jul 8;15(1):24402. doi: 10.1038/s41598-025-09511-z.

DOI:10.1038/s41598-025-09511-z
PMID:40628874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12238471/
Abstract

Uganda is consistently one of the highest burden countries for mother-to-child transmission of HIV (MTCT). This study assessed Uganda's progress toward elimination of MTCT and factors associated with MTCT. Mother-infant pairs (MIP) were recruited at immunization clinics at randomly sampled public and private health facilities in Uganda during 2017-2019. Using a multistage sampling method, a nationally representative sample of MIP aged 4-12 weeks were recruited and followed longitudinally for 18 months or until the infant acquired HIV. Early MTCT was defined as an infant with confirmed HIV infection at study enrollment and was calculated using logistic regression to estimate adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) for associated factors. Poisson regression was used to estimate incidence rate and incidence rate ratio (IRR) for infants acquiring HIV at any time during the study after enrollment (late MTCT) and associated factors. Early MTCT was 2.2% (95% CI: 1.3-3.6) and late MTCT rate was 5.2 per 1000 person-years (95% CI: 2.5-10.9). In the adjusted model, only detectable maternal HIV viral load (≥ 1,000 copies/mL) was significantly associated with early MTCT (aOR: 6.8, 95% CI: 2.3-19.9). Similarly, ever having a detectable viral load (at any visit) was significantly associated with late MTCT (IRR: 6.2, 95% CI: 1.2-31.7). Uganda's program has made large strides to eliminate MTCT. Identifying and addressing elevated maternal HIV viral load, especially during pregnancy and the early breastfeeding period could further reduce the number of new childhood infections in Uganda.

摘要

乌干达一直是艾滋病毒母婴传播(MTCT)负担最高的国家之一。本研究评估了乌干达在消除MTCT方面的进展以及与MTCT相关的因素。2017年至2019年期间,在乌干达随机抽取的公立和私立卫生设施的免疫诊所招募母婴对(MIP)。采用多阶段抽样方法,招募了具有全国代表性的4至12周龄MIP样本,并对其进行了18个月的纵向跟踪,或直至婴儿感染艾滋病毒。早期MTCT定义为在研究入组时确诊感染艾滋病毒的婴儿,并使用逻辑回归计算相关因素的调整优势比(aOR)和95%置信区间(95%CI)。采用泊松回归估计入组后研究期间任何时间感染艾滋病毒的婴儿(晚期MTCT)的发病率和发病率比(IRR)以及相关因素。早期MTCT为2.2%(95%CI:1.3 - 3.6),晚期MTCT率为每1000人年5.2例(95%CI:2.5 - 10.9)。在调整模型中,仅可检测到的母亲艾滋病毒病毒载量(≥1000拷贝/mL)与早期MTCT显著相关(aOR:6.8,95%CI:2.3 - 19.9)。同样,曾经有过可检测到的病毒载量(在任何一次就诊时)与晚期MTCT显著相关(IRR:6.2,95%CI:1.2 - 31.7)。乌干达的项目在消除MTCT方面取得了长足进展。识别并解决母亲艾滋病毒病毒载量升高的问题,尤其是在孕期和母乳喂养早期,可能会进一步减少乌干达新的儿童感染病例数。

相似文献

1
An impact evaluation of the national prevention of mother to child HIV transmission program and MTCT associated factors in Uganda 2017-2019.2017 - 2019年乌干达全国预防母婴传播艾滋病毒项目及母婴传播相关因素的影响评估
Sci Rep. 2025 Jul 8;15(1):24402. doi: 10.1038/s41598-025-09511-z.
2
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
3
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
4
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低人类免疫缺陷病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003510. doi: 10.1002/14651858.CD003510.pub2.
5
Interventions for preventing late postnatal mother-to-child transmission of HIV.预防产后晚期母婴传播艾滋病毒的干预措施。
Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006734. doi: 10.1002/14651858.CD006734.pub2.
6
Mortality rates in a cohort of infants attending immunization clinics in Uganda (2017-2019).乌干达免疫接种诊所的一组婴儿(2017 - 2019年)的死亡率。
PLoS One. 2025 May 23;20(5):e0324122. doi: 10.1371/journal.pone.0324122. eCollection 2025.
7
Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.补充维生素A以降低母婴传播HIV感染的风险。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD003648. doi: 10.1002/14651858.CD003648.pub2.
8
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低母婴传播HIV感染风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2002(1):CD003510. doi: 10.1002/14651858.CD003510.
9
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低母婴传播HIV感染风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2002(2):CD003510. doi: 10.1002/14651858.CD003510.
10
Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.补充维生素A以降低母婴传播艾滋病毒感染的风险。
Cochrane Database Syst Rev. 2011 Jan 19(1):CD003648. doi: 10.1002/14651858.CD003648.pub3.

本文引用的文献

1
Scale-Up of HIV Antiretroviral Therapy and Estimation of Averted Infections and HIV-Related Deaths - Uganda, 2004-2022.扩大艾滋病毒抗逆转录病毒治疗规模和估计可避免的感染和艾滋病毒相关死亡-乌干达,2004-2022 年。
MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):90-94. doi: 10.15585/mmwr.mm7204a2.
2
Twenty years of Prevention of Mother to Child HIV Transmission: research to implementation at a national referral hospital in Uganda.二十年来预防母婴 HIV 传播的工作:乌干达国家转诊医院的研究与实施。
Afr Health Sci. 2022 Aug;22(Spec Issue):22-33. doi: 10.4314/ahs.v22i2.5S.
3
Determinants of HIV infection among children born to HIV positive mothers on prevention of mother to child transmission program at referral hospitals in west Amhara, Ethiopia; case control study.在埃塞俄比亚西阿姆哈拉转诊医院,预防母婴传播项目中 HIV 阳性母亲所生儿童的 HIV 感染决定因素;病例对照研究。
Ital J Pediatr. 2022 Feb 3;48(1):17. doi: 10.1186/s13052-022-01220-x.
4
Coverage of maternal viral load monitoring during pregnancy in South Africa: Results from the 2019 national Antenatal HIV Sentinel Survey.南非孕期母婴病毒载量监测的覆盖情况:来自 2019 年全国产前 HIV 哨点监测的结果。
HIV Med. 2021 Oct;22(9):805-815. doi: 10.1111/hiv.13126. Epub 2021 Jul 1.
5
Barriers and enablers of adherence to infant nevirapine prophylaxis against HIV 1 transmission among 6-week-old HIV exposed infants: A prospective cohort study in Northern Uganda.在乌干达北部,对 6 周龄 HIV 暴露婴儿进行婴儿奈韦拉平预防 HIV1 传播的依从性的障碍和促进因素:一项前瞻性队列研究。
PLoS One. 2020 Oct 15;15(10):e0240529. doi: 10.1371/journal.pone.0240529. eCollection 2020.
6
HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.南非开普敦孕期开始抗逆转录病毒治疗后的艾滋病毒血症及母婴传播风险
HIV Med. 2017 Feb;18(2):80-88. doi: 10.1111/hiv.12397. Epub 2016 Jun 28.
7
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.从开始于妊娠前的有效的抗逆转录病毒治疗的女性中无围产期 HIV-1 传播。
Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21.
8
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.
9
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.单剂量奈韦拉平方案对撒哈拉以南非洲地区母婴降低HIV-1垂直传播的成本效益分析
Lancet. 1999 Sep 4;354(9181):803-9. doi: 10.1016/S0140-6736(99)80009-9.